|Date & Time||8 February 2023 (10:00 – 11:30 CET)|
Do you need translational assessment or detailed biomarker development information for your new diagnostics? The Codex4SMEs support programme offers diagnostics SMEs various services. In the information session, you will learn from experts from EATRIS and IBBL about the scope of services available for your needs.
The Interreg North-West Europe Codex4SMEs support programme offers a wide range of services to small and medium-sized enterprises (SMEs) in the life sciences and medical technology sectors working on the development of diagnostics.
The information event provides attendees with details about the application process for Codex4SMEs services, eligibility criteria for applicants, and the scope of services. Experts from EATRIS and IBBL will present details of the following services:
- Translational assessment provided by EATRIS
- Modular biomarker validation services provided by IBBL
- Tailored consultancy services on specific biomarker topics provided by IBBL
- Interactive online seminars on biomarker validation topics provided by IBBL
EATRIS Translational Assessment supports SMEs in assessing and optimising the translational feasibility and potential of their projects. By providing feedback on issues such as medical need, market and pipeline overview, regulatory pathway, intellectual property and translational tools, early-stage companies can optimise their plans according to the realities of the development pipeline.
The Translational Biomarker Group at the Integrated Biobank of Luxembourg (IBBL) supports SMEs by providing a biomarker pre-clinical validation service. Biomarker technical validation is an essential tool to increase the chances for a successful exploitation of newly discovered and repurposable biomarkers into powerful diagnostic tools, predictors for proper treatments, or Companion Diagnostics (Cdx).